News Articles Tagged: Parkinson's Disease Science

The Science Behind Safinamide Mesylate: A Pharmaceutical Chemical Explained

NINGBO INNO PHARMCHEM CO.,LTD. explores the scientific basis of Safinamide Mesylate (CAS 202825-46-5), detailing its MAO-B inhibitory action and its significance as a high-purity pharmaceutical intermediate for Parkinson's disease.

Enhancing Parkinson's Treatment: The Science Behind Benserazide Hydrochloride and Levodopa

Delve into the scientific synergy between Benserazide Hydrochloride and Levodopa for Parkinson's treatment. Understand how this combination works as a peripheral decarboxylase inhibitor and levodopa bioavailability enhancer. Sourced from NINGBO INNO PHARMCHEM CO.,LTD.

The Science Behind Natural Levodopa: How Mucuna Pruriens Supports Dopamine Levels

Delve into the scientific evidence supporting Mucuna Pruriens as a source of natural levodopa and its impact on dopamine levels and Parkinson's disease symptom management.